This content is from: Features

The life and times of a GSK patent

Carl Battle has a big job on his hands managing pharmaceutical giant GlaxoSmithKline’s patent team. Michael Loney talks to him and some of his staff about bringing Anoro Ellipta to market, the dreaded patent cliff, combating generic drug companies and navigating developing countries’ IP hostility

Get Free Access to read more …

To read the full article, activate your free trial.

Get Free Access
  • Unlimited articles for one week
  • No commitments; no payment details required
  • Featuring IP strategy, copyright, patents, trademark and more!

Are you a Managing IP subscriber? Simply login here.

Related